News
Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory diseases, today ...
With Rare Disease Day tomorrow, its coordinator EURORDIS has honoured Sanofi’s Genzyme with the highly acclaimed Company Award for its rare disease accomplishments. The largest European rare ...
The Kennedy Center, meanwhile, has seen subscription sales plummet by more than a third year-on-year in the wake of Trump’s takeover.
Genzyme continued to drive growth for Sanofi in the first quarter, helped along by the company’s vaccines unit, but diabetes drugs are still struggling. Net sales were €8,391 million, an ...
Discover the best call center software available today. We selected these options based on factors such as key features, uptime, pricing and more.
Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid ...
Relapsing Multiple Sclerosis: Navigating Treatment Conundrums This activity is supported by an educational grant from Novartis Pharmaceuticals, Inc.
Current state and historical patterns in the gender, ethnic, and age diversity of UC employee segments using various interactive filters. (Back to 2011.) This dashboard offers systemwide data on UC ...
Data center stocks include, but are not limited to, real estate investment trusts, or REITs, that own and operate data centers.
See the latest BioMarin Pharmaceutical Inc stock price (BMRN:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
Partners of the Year: Sanofi Genzyme fine-tunes Dimock Center strategy Sep 6, 2018, 8:00 pm EDT CORPORATE CITIZENSHIP AWARDS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results